Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 174

1.

Use of Diabetes Technology in Children: Role of Structured Education for Young People with Diabetes and Families.

Desrochers HR, Schultz AT, Laffel LM.

Endocrinol Metab Clin North Am. 2020 Mar;49(1):19-35. doi: 10.1016/j.ecl.2019.11.001. Review.

PMID:
31980118
2.

Randomized Controlled Trial of Mobile Closed-Loop Control.

Kovatchev B, Anderson SM, Raghinaru D, Kudva YC, Laffel LM, Levy C, Pinsker JE, Wadwa RP, Buckingham B, Doyle FJ 3rd, Brown SA, Church MM, Dadlani V, Dassau E, Ekhlaspour L, Forlenza GP, Isganaitis E, Lam DW, Lum J, Beck RW; iDCL Study Group.

Diabetes Care. 2020 Jan 14. pii: dc191310. doi: 10.2337/dc19-1310. [Epub ahead of print]

PMID:
31937608
3.

Low-dose empagliflozin as adjunct-to-insulin therapy in type 1 diabetes: A valid modelling and simulation analysis to confirm efficacy.

Perkins BA, Soleymanlou N, Rosenstock J, Skyler JS, Laffel LM, Liesenfeld KH, Neubacher D, Riggs MM, Johnston CK, Eudy-Byrne RJ, Elmokadem A, George JT, Marquard J, Nock V.

Diabetes Obes Metab. 2019 Dec 19. doi: 10.1111/dom.13945. [Epub ahead of print]

PMID:
31858718
4.

"I'm essentially his pancreas": Parent perceptions of diabetes burden and opportunities to reduce burden in the care of children <8 years old with type 1 diabetes.

Commissariat PV, Harrington KR, Whitehouse AL, Miller KM, Hilliard ME, Van Name M, DeSalvo DJ, Tamborlane WV, Anderson BJ, DiMeglio LA, Laffel LM.

Pediatr Diabetes. 2020 Mar;21(2):377-383. doi: 10.1111/pedi.12956. Epub 2019 Dec 16.

PMID:
31808586
5.

Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes.

Brown SA, Kovatchev BP, Raghinaru D, Lum JW, Buckingham BA, Kudva YC, Laffel LM, Levy CJ, Pinsker JE, Wadwa RP, Dassau E, Doyle FJ 3rd, Anderson SM, Church MM, Dadlani V, Ekhlaspour L, Forlenza GP, Isganaitis E, Lam DW, Kollman C, Beck RW; iDCL Trial Research Group.

N Engl J Med. 2019 Oct 31;381(18):1707-1717. doi: 10.1056/NEJMoa1907863. Epub 2019 Oct 16.

PMID:
31618560
6.

Identity and treatment adherence in predominantly ethnic minority teens and young adults with type 1 diabetes.

Commissariat PV, Laffel LM, Gonzalez JS.

Pediatr Diabetes. 2020 Feb;21(1):53-60. doi: 10.1111/pedi.12932. Epub 2019 Oct 23.

PMID:
31603620
7.

Advances in technology for management of type 1 diabetes.

Beck RW, Bergenstal RM, Laffel LM, Pickup JC.

Lancet. 2019 Oct 5;394(10205):1265-1273. doi: 10.1016/S0140-6736(19)31142-0. Epub 2019 Sep 15. Review.

PMID:
31533908
8.

A mobile app identifies momentary psychosocial and contextual factors related to mealtime self-management in adolescents with type 1 diabetes.

Mulvaney SA, Vaala SE, Carroll RB, Williams LK, Lybarger CK, Schmidt DC, Dietrich MS, Laffel LM, Hood KK.

J Am Med Inform Assoc. 2019 Dec 1;26(12):1627-1631. doi: 10.1093/jamia/ocz147.

PMID:
31529065
9.

Predictors of response to insulin therapy in youth with poorly-controlled type 2 diabetes in the TODAY trial.

Bacha F, El Ghormli L, Arslanian S, Zeitler P, Laffel LM, Levitt Katz LE, Gandica R, Chang NT, Sprague JE, Macleish SA; TODAY Study Group.

Pediatr Diabetes. 2019 Nov;20(7):871-879. doi: 10.1111/pedi.12906. Epub 2019 Aug 27.

PMID:
31418516
10.

"Let's talk about it" The role of parental communication in adolescents' motivation to adhere to treatment recommendations for type 1 diabetes.

Goethals ER, Soenens B, de Wit M, Vansteenkiste M, Laffel LM, Casteels K, Luyckx K.

Pediatr Diabetes. 2019 Nov;20(7):1025-1034. doi: 10.1111/pedi.12901. Epub 2019 Aug 16.

11.

Distinct Patterns of Daily Glucose Variability by Pubertal Status in Youth With Type 1 Diabetes.

Zhu J, Volkening LK, Laffel LM.

Diabetes Care. 2020 Jan;43(1):22-28. doi: 10.2337/dc19-0083. Epub 2019 Jul 15.

PMID:
31308020
12.

Greater parental comfort with lower glucose targets in young children with Type 1 diabetes using continuous glucose monitoring.

Van Name MA, Miller KM, Commissariat PV, Whitehouse AL, Harrington KR, Anderson BJ, Mantravadi MG, Levy W, DeSalvo DJ, Tamborlane WV, Hilliard ME, Laffel LM, DiMeglio LA.

Diabet Med. 2019 Nov;36(11):1508-1510. doi: 10.1111/dme.14074. Epub 2019 Jul 25. No abstract available.

PMID:
31295359
13.

Benefits and Barriers of Continuous Glucose Monitoring in Young Children with Type 1 Diabetes.

Hilliard ME, Levy W, Anderson BJ, Whitehouse AL, Commissariat PV, Harrington KR, Laffel LM, Miller KM, Van Name M, Tamborlane WV, DeSalvo DJ, DiMeglio LA.

Diabetes Technol Ther. 2019 Sep;21(9):493-498. doi: 10.1089/dia.2019.0142. Epub 2019 Jul 9.

PMID:
31287721
14.

Autism spectrum disorder in children with Type 1 diabetes.

Bethin KE, Kanapka LG, Laffel LM, Majidi S, Chaytor NS, MacLeish S, Adams R, Foster NC; T1D Exchange Clinic Network.

Diabet Med. 2019 Jul 4. doi: 10.1111/dme.14069. [Epub ahead of print]

PMID:
31271682
15.

Exploring Patient Preferences for Adjunct-to-Insulin Therapy in Type 1 Diabetes.

Perkins BA, Rosenstock J, Skyler JS, Laffel LM, Cherney DZ, Mathieu C, Pang C, Wood R, Kinduryte O, George JT, Marquard J, Soleymanlou N.

Diabetes Care. 2019 Sep;42(9):1716-1723. doi: 10.2337/dc19-0548. Epub 2019 Jun 8.

PMID:
31177179
16.

Healthcare and associated costs related to type 2 diabetes in youth and adolescence: the TODAY clinical trial experience.

Songer TJ, Haymond MW, Glazner JE, Klingensmith GJ, Laffel LM, Zhang P, Hirst K; TODAY Study Group.

Pediatr Diabetes. 2019 Sep;20(6):702-711. doi: 10.1111/pedi.12869. Epub 2019 Jun 6.

17.

Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec, in Children and Adolescents With Type 1 Diabetes: The onset 7 Trial.

Bode BW, Iotova V, Kovarenko M, Laffel LM, Rao PV, Deenadayalan S, Ekelund M, Larsen SF, Danne T.

Diabetes Care. 2019 Jul;42(7):1255-1262. doi: 10.2337/dc19-0009. Epub 2019 May 10.

PMID:
31076415
18.

Self-Monitoring of Blood Glucose in Youth-Onset Type 2 Diabetes: Results From the TODAY Study.

Weinstock RS, Braffett BH, McGuigan P, Larkin ME, Grover NB, Walders-Abramson N, Laffel LM, Chan CL, Chang N, Schwartzman BE, Barajas RA, Celona-Jacobs N, Haymond MW; TODAY Study Group.

Diabetes Care. 2019 May;42(5):903-909. doi: 10.2337/dc18-1854. Epub 2019 Mar 4.

PMID:
30833375
19.

Assessing patient-reported outcomes for automated insulin delivery systems: the psychometric properties of the INSPIRE measures.

Weissberg-Benchell J, Shapiro JB, Hood K, Laffel LM, Naranjo D, Miller K, Barnard K.

Diabet Med. 2019 May;36(5):644-652. doi: 10.1111/dme.13930. Epub 2019 Mar 20.

20.

Text-message responsiveness to blood glucose monitoring reminders is associated with HbA1c benefit in teenagers with Type 1 diabetes.

McGill DE, Volkening LK, Butler DA, Wasserman RM, Anderson BJ, Laffel LM.

Diabet Med. 2019 May;36(5):600-605. doi: 10.1111/dme.13929. Epub 2019 Feb 25.

PMID:
30734361
21.

Factors associated with disordered eating behaviours in adolescents with Type 1 diabetes.

Cecilia-Costa R, Volkening LK, Laffel LM.

Diabet Med. 2019 Aug;36(8):1020-1027. doi: 10.1111/dme.13890. Epub 2019 Mar 4.

PMID:
30582670
22.

Determination of Pubertal Status in Youths With Type 1 Diabetes Using Height Velocity and Trajectories.

Zhu J, Volkening LK, Laffel LM.

J Clin Endocrinol Metab. 2019 Jan 1;104(1):74-82. doi: 10.1210/jc.2018-01737.

23.

Empagliflozin as Adjunctive to Insulin Therapy in Type 1 Diabetes: The EASE Trials.

Rosenstock J, Marquard J, Laffel LM, Neubacher D, Kaspers S, Cherney DZ, Zinman B, Skyler JS, George J, Soleymanlou N, Perkins BA.

Diabetes Care. 2018 Dec;41(12):2560-2569. doi: 10.2337/dc18-1749. Epub 2018 Oct 4.

PMID:
30287422
24.

Management of cardiovascular disease risk in teens with type 1 diabetes: Perspectives of teens with and without dyslipidemia and parents.

Katz ML, Guo Z, Cheema A, Laffel LM.

Pediatr Diabetes. 2019 Mar;20(2):210-216. doi: 10.1111/pedi.12771.

PMID:
30209870
25.

Type 1 Diabetes in Children and Adolescents: A Position Statement by the American Diabetes Association.

Chiang JL, Maahs DM, Garvey KC, Hood KK, Laffel LM, Weinzimer SA, Wolfsdorf JI, Schatz D.

Diabetes Care. 2018 Sep;41(9):2026-2044. doi: 10.2337/dci18-0023. Epub 2018 Aug 9. No abstract available.

26.

ISPAD Clinical Practice Consensus Guidelines 2018: Sick day management in children and adolescents with diabetes.

Laffel LM, Limbert C, Phelan H, Virmani A, Wood J, Hofer SE.

Pediatr Diabetes. 2018 Oct;19 Suppl 27:193-204. doi: 10.1111/pedi.12741. No abstract available.

PMID:
30079506
27.

Management of Type 1 Diabetes With a Very Low-Carbohydrate Diet: A Word of Caution.

Mayer-Davis EJ, Laffel LM, Buse JB.

Pediatrics. 2018 Aug;142(2). pii: e20181536B. doi: 10.1542/peds.2018-1536B. No abstract available.

28.

Performance of a Factory-Calibrated Real-Time Continuous Glucose Monitoring System Utilizing an Automated Sensor Applicator.

Shah VN, Laffel LM, Wadwa RP, Garg SK.

Diabetes Technol Ther. 2018 Jun;20(6):428-433. doi: 10.1089/dia.2018.0143.

29.

Accuracy of a Factory-Calibrated, Real-Time Continuous Glucose Monitoring System During 10 Days of Use in Youth and Adults with Diabetes.

Wadwa RP, Laffel LM, Shah VN, Garg SK.

Diabetes Technol Ther. 2018 Jun;20(6):395-402. doi: 10.1089/dia.2018.0150. Epub 2018 Jun 14.

30.

Predictors of changing insulin dose requirements and glycaemic control in children, adolescents and young adults with Type 1 diabetes.

Teló GH, Dougher CE, Volkening LK, Katz ML, Laffel LM.

Diabet Med. 2018 Oct;35(10):1355-1363. doi: 10.1111/dme.13699. Epub 2018 Jun 19.

31.

Baseline Psychosocial Characteristics Predict Frequency of Continuous Glucose Monitoring in Youth with Type 1 Diabetes.

McGill DE, Volkening LK, Butler DA, Harrington KR, Katz ML, Laffel LM.

Diabetes Technol Ther. 2018 Jun;20(6):434-439. doi: 10.1089/dia.2018.0037. Epub 2018 May 4.

32.

Pharmacokinetic and pharmacodynamic profile of the sodium-glucose co-transporter-2 inhibitor empagliflozin in young people with Type 2 diabetes: a randomized trial.

Laffel LMB, Tamborlane WV, Yver A, Simons G, Wu J, Nock V, Hobson D, Hughan KS, Kaspers S, Marquard J.

Diabet Med. 2018 Aug;35(8):1096-1104. doi: 10.1111/dme.13629. Epub 2018 May 6.

33.

Automated Insulin Delivery Systems: Hopes and Expectations of Family Members.

Garza KP, Jedraszko A, Weil LEG, Naranjo D, Barnard KD, Laffel LMB, Hood KK, Weissberg-Benchell J.

Diabetes Technol Ther. 2018 Mar;20(3):222-228. doi: 10.1089/dia.2017.0301.

34.

Comparison of Surgical and Medical Therapy for Type 2 Diabetes in Severely Obese Adolescents.

Inge TH, Laffel LM, Jenkins TM, Marcus MD, Leibel NI, Brandt ML, Haymond M, Urbina EM, Dolan LM, Zeitler PS; Teen–Longitudinal Assessment of Bariatric Surgery (Teen-LABS) and Treatment Options of Type 2 Diabetes in Adolescents and Youth (TODAY) Consortia.

JAMA Pediatr. 2018 May 1;172(5):452-460. doi: 10.1001/jamapediatrics.2017.5763.

35.

Management of Hypertension and High Low-Density Lipoprotein in Pediatric Type 1 Diabetes.

Katz ML, Guo Z, Laffel LM.

J Pediatr. 2018 Jun;197:140-146.e12. doi: 10.1016/j.jpeds.2017.11.059. Epub 2018 Feb 1.

36.

Disordered Eating Behaviors Are Not Increased by an Intervention to Improve Diet Quality but Are Associated With Poorer Glycemic Control Among Youth With Type 1 Diabetes.

Eisenberg Colman MH, Quick VM, Lipsky LM, Dempster KW, Liu A, Laffel LMB, Mehta SN, Nansel TR.

Diabetes Care. 2018 Apr;41(4):869-875. doi: 10.2337/dc17-0090. Epub 2018 Jan 25.

37.

A Practical Approach to Using Trend Arrows on the Dexcom G5 CGM System to Manage Children and Adolescents With Diabetes.

Laffel LM, Aleppo G, Buckingham BA, Forlenza GP, Rasbach LE, Tsalikian E, Weinzimer SA, Harris DR.

J Endocr Soc. 2017 Nov 20;1(12):1461-1476. doi: 10.1210/js.2017-00389. eCollection 2017 Dec 1.

38.

A Practical Approach to Using Trend Arrows on the Dexcom G5 CGM System for the Management of Adults With Diabetes.

Aleppo G, Laffel LM, Ahmann AJ, Hirsch IB, Kruger DF, Peters A, Weinstock RS, Harris DR.

J Endocr Soc. 2017 Nov 20;1(12):1445-1460. doi: 10.1210/js.2017-00388. eCollection 2017 Dec 1.

39.

Erratum. Factors Associated With Diabetes-Specific Health-Related Quality of Life in Youth With Type 1 Diabetes: The Global TEENs Study. Diabetes Care 2017;40:1002-1009.

Anderson BJ, Laffel LM, Domenger C, Danne T, Phillip M, Mazza C, Hanas R, Waldron S, Beck RW, Calvi-Gries F, Mathieu C.

Diabetes Care. 2018 Mar;41(3):640. doi: 10.2337/dc18-er03. Epub 2018 Jan 10. No abstract available.

40.

Depressive Symptoms at Critical Times in Youth With Type 1 Diabetes: Following Type 1 Diabetes Diagnosis and Insulin Pump Initiation.

McGill DE, Volkening LK, Pober DM, Muir AB, Young-Hyman DL, Laffel LM.

J Adolesc Health. 2018 Feb;62(2):219-225. doi: 10.1016/j.jadohealth.2017.09.017. Epub 2017 Dec 6.

41.

Randomized, double-blind, placebo-controlled dose-finding study of the dipeptidyl peptidase-4 inhibitor linagliptin in pediatric patients with type 2 diabetes.

Tamborlane WV, Laffel LM, Weill J, Gordat M, Neubacher D, Retlich S, Hettema W, Hoesl CE, Kaspers S, Marquard J.

Pediatr Diabetes. 2018 Jun;19(4):640-648. doi: 10.1111/pedi.12616. Epub 2017 Nov 24.

PMID:
29171139
42.

Management and Family Burdens Endorsed by Parents of Youth <7 Years Old With Type 1 Diabetes.

Harrington KR, Boyle CT, Miller KM, Hilliard ME, Anderson BJ, Van Name M, DiMeglio LA, Laffel LM; T1D Exchange Clinic Network.

J Diabetes Sci Technol. 2017 Sep;11(5):980-987. doi: 10.1177/1932296817721938. Epub 2017 Aug 3.

43.

RETRACTED: Management and Family Burdens Endorsed by Parents of Youth <7 Years Old With Type 1 Diabetes.

Harrington K, Boyle CT, Miller KM, Hilliard ME, Anderson BJ, Van Name M, DiMeglio LA, Laffel LM; T1D Exchange Clinic Network.

J Diabetes Sci Technol. 2017 Feb 1:1932296817693255. doi: 10.1177/1932296817693255. [Epub ahead of print] No abstract available.

PMID:
28627221
44.

Practical Considerations on the Use of Continuous Glucose Monitoring in Pediatrics and Older Adults and Nonadjunctive Use.

Forlenza GP, Argento NB, Laffel LM.

Diabetes Technol Ther. 2017 Jun;19(S3):S13-S20. doi: 10.1089/dia.2017.0034. Review.

45.

Insulin Pump Use in Young Children with Type 1 Diabetes: Sociodemographic Factors and Parent-Reported Barriers.

Commissariat PV, Boyle CT, Miller KM, Mantravadi MG, DeSalvo DJ, Tamborlane WV, Van Name MA, Anderson BJ, DiMeglio LA, Laffel LM.

Diabetes Technol Ther. 2017 Jun;19(6):363-369. doi: 10.1089/dia.2016.0375. Epub 2017 Jun 5.

46.

Factors Associated With Diabetes-Specific Health-Related Quality of Life in Youth With Type 1 Diabetes: The Global TEENs Study.

Anderson BJ, Laffel LM, Domenger C, Danne T, Phillip M, Mazza C, Hanas R, Waldron S, Beck RW, Calvi-Gries F, Mathieu C.

Diabetes Care. 2017 Aug;40(8):1002-1009. doi: 10.2337/dc16-1990. Epub 2017 May 25. Erratum in: Diabetes Care. 2018 Jan 10;:.

47.

Examination of Psychosocial and Physiological Risk for Bulimic Symptoms in Youth With Type 1 Diabetes Transitioning to an Insulin Pump: A Pilot Study.

Peterson CM, Young-Hyman D, Fischer S, Markowitz JT, Muir AB, Laffel LM.

J Pediatr Psychol. 2018 Jan 1;43(1):83-93. doi: 10.1093/jpepsy/jsx084.

48.

Nighttime is the worst time: Parental fear of hypoglycemia in young children with type 1 diabetes.

Van Name MA, Hilliard ME, Boyle CT, Miller KM, DeSalvo DJ, Anderson BJ, Laffel LM, Woerner SE, DiMeglio LA, Tamborlane WV.

Pediatr Diabetes. 2018 Feb;19(1):114-120. doi: 10.1111/pedi.12525. Epub 2017 Apr 21.

49.

Associations between major life events and adherence, glycemic control, and psychosocial characteristics in teens with type 1 diabetes.

Commissariat PV, Volkening LK, Guo Z, ElBach JL, Butler DA, Laffel LM.

Pediatr Diabetes. 2018 Feb;19(1):85-91. doi: 10.1111/pedi.12523. Epub 2017 Apr 19.

50.

Exercise management in type 1 diabetes: a consensus statement.

Riddell MC, Gallen IW, Smart CE, Taplin CE, Adolfsson P, Lumb AN, Kowalski A, Rabasa-Lhoret R, McCrimmon RJ, Hume C, Annan F, Fournier PA, Graham C, Bode B, Galassetti P, Jones TW, Millán IS, Heise T, Peters AL, Petz A, Laffel LM.

Lancet Diabetes Endocrinol. 2017 May;5(5):377-390. doi: 10.1016/S2213-8587(17)30014-1. Epub 2017 Jan 24. Review. Erratum in: Lancet Diabetes Endocrinol. 2017 May;5(5):e3.

PMID:
28126459

Supplemental Content

Loading ...
Support Center